Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: Harnessing natural and adaptive immunity

Seminars in Oncology

Volumn 39, Issue 6, 2012, Pages 643-652

  Aversa, Franco ^a   Martelli, Massimo F ^b   Velardi, Andrea ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; HLA ANTIGEN; THIOTEPA; THYMOCYTE ANTIBODY;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ARTICLE; EVENT FREE SURVIVAL; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INNATE IMMUNITY; LEUKEMIA; LEUKEMIA RELAPSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; TREATMENT OUTCOME;

ADAPTIVE IMMUNITY; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 84870723622     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.09.002     Document Type: Article

References (105)

1. T. Lodewyck, J.J. Cornelissen Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach Blood Rev 22 2008 293 302
2. A.K. Burnett, K. Wheatley, A.H. Goldstone The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial Br J Haematol 118 2002 385 400
3. J.C. Byrd, K. Mrozek, R.K. Dodge Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 2002 4325 4336
4. S.J. Forman, G.M. Schmidt, A.P. Nademanee Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia J Clin Oncol 9 1991 1570 1574
5. S.M. Davies, C. Kollman, C. Anasetti Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program Blood 96 2000 4096 4102
6. R. Szydlo, J.M. Goldman, J.P. Klein Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 15 1997 1767 1777
7. B.E. Shaw, R. Arguello, C.A. Garcia-Sepulveda, J.A. Madrigal The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation Br J Haematol 150 2010 251 258
8. V. Rocha, M. Labopin, G. Sanz Transplants of umbilical cord blood or bone marrow from unrelated donors in adult with leukemia N Engl J Med 351 2004 2276 2285
9. C.G. Brunstein, D.C. Setubal, J.E. Wagner Expanding the role of umbilical cord blood transplantation Br J Haematol 137 2007 20 35
10. J.E. Wagner, E. Gluckman Umbilical cord blood transplantation: the first 20 years Semin Hematol 47 2010 3 12
11. F. Aversa, A. Tabilio, A. Velardi Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med 339 1998 1186 1193
12. M.F. Martelli, F. Aversa, E. Bachar-Lusting Transplants across human leukocyte antigen barriers Semin Hematol 39 2002 48 56
13. F. Aversa, A. Terenzi, A. Tabilio Full-haplotype mismatched hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk or relapse J Clin Oncol 23 2005 3447 3454
14. H.J. Symons, E.J. Fuchs Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors Bone Marrow Transplant 42 2008 365 377
15. Y. Reisner, D. Hagin, M.F. Martelli Haploidentical hematopoietic transplantation: current status and future perspectives Blood 118 2011 6006 6017
16. P. Parham MHC class I molecules and KIRs in human history, health and survival Nat Rev Immunol 5 2005 201 214
17. M. Yawata, N. Yawata, M. Draghi, A.M. Little, F. Parteniou, P. Parham Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function J Exp Med 203 2006 633 645
18. W. Leung, R. Iyengar, V. Turner Determinants of antileukemia effects of allogeneic NK cells J Immunol 172 2004 644 650
19. L. Ruggeri, M. Capanni, E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
20. A. Velardi, L. Ruggeri, A. Moretta, L. Moretta NK cells: a lesson from mismatched hematopoietic transplantation Trends Immunol 23 2002 438 444
21. L. Moretta, A. Moretta Killer immunoglobulin-like receptors Curr Opin Immunol 16 2004 626 633
22. L. Ruggeri, A. Mancusi, M. Capanni Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value Blood 110 2007 433 440
23. L. Ruggeri, A. Mancusi, E. Burchielli, F. Aversa, M.F. Martelli, A. Velardi Natural killer cell alloreactivity in allogeneic hematopoietic transplantation Curr Opin Oncol 19 2007 142 147
24. L. Ruggeri, M. Capanni, M. Casucci Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 1999 333 339
25. M. Stern, L. Ruggeri, A. Mancusi Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor Blood 112 2008 2990 2995
26. L. Moretta, F. Locatelli, D. Pende, E. Marcenaro, M.C. Mingari, A. Moretta Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation Blood 117 2011 764 771
27. R. Willemze, A. Ruggeri, D. Purtill Eurocord and of the European Group of Blood and Marrow Transplantation Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation? Best Pract Res Clin Haematol 23 2010 283 290
28. C. Anasetti, P.G. Beatty, R. Storb Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma Hum Immunol 29 1990 79 91
29. N.A. Kernan, N.H. Collins, L. Juliano, T. Cartagena, B. Dupont, R.J. O'Reilly Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease Blood 68 1986 770 773
30. Y. Reisner, I. Ben-Bassat, D. Douer, A. Kaploon, E. Schwartz, B. Ramot Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation Proc Natl Acad Sci U S A 83 1986 4012 4015
31. N.A. Kernan, N. Flomemberg, B. Dupont, R.J. O'Reilly Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia: identification of host derived anti-donor allocytotoxic T lymphocytes Transplantation 43 1987 482 487
32. P.J. Henslee-Downey, S.H. Abhyankar, R.S. Parrish Use of partially mismatched related donors extends access to allogeneic marrow transplant Blood 89 1987 3864 3872
33. Y. Reisner, N. Kapoor, D. Kirkpatrick Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 61 1983 341 348
34. R.C. Ash, M.M. Horowitz, R.P. Gale Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion Bone Marrow Transplant 7 1991 443 452
35. J. Mehta, S. Singhal, A.P. Gee Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients Bone Marrow Transplant 33 2004 389 396
36. Y. Reisner Engraftment of T-cell-depleted bone marrow in murine models for allogeneic bone marrow transplantation Cancer Treat Res 50 1990 9 25
37. E. Bachar-Lusting, N. Rachamim, H.W. Li, F. Lan, Y. Reisner Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med 1 1995 1268 1273
38. N. Rachamin, J. Gan, H. Segall Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture Transplantation 65 1998 1386 1393
39. H. Gur, R. Krauthgamer, A. Berrebi Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells Blood 99 2002 4174 4181
40. H. Gur, R. Krauthgamer, E. Bachar-Lustig Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha Blood 105 2005 2585 2593
41. F. Aversa, A. Tabilio, A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
42. A. Terenzi, C. Aristei, F. Aversa Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results Transplant Proc 28 1996 3101
43. E.K. Waller, A.A. Langston, S. Lonial Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biol Blood Marrow Transplant 9 2003 460 471
44. M.M. Horowitz, R.P. Gale, P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555 562
45. A.M. Marmont, M.M. Horowitz, R.P. Gale T-cell depletion of HLA-identical transplants in leukemia Blood 78 1991 2120 2130
46. J.M. Li, C.R. Giver, Y. Lu, M.S. Hossain, M. Akhtari, E.K. Waller Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation Immunotherapy 1 2009 599 621
47. F. Aversa, Y. Reisner, M.F. Martelli The haploidentical option for high-risk haematological malignancies Blood Cells Mol Dis 40 2008 8 12
48. F. Ciceri, M. Labopin, F. Aversa A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation Blood 112 2008 3574 3581
49. R. Handgretinger, T. Klingebiel, P. Lang Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children Bone Marrow Transplant 27 2001 777 783
50. P. Lang, J. Greil, P. Bader Long-term outcome after haploidentical stem cell transplantation in children Blood Cells Mol Dis 33 2004 281 287
51. F. Locatelli, D. Pende, R. Maccario, M.C. Mingari, A. Moretta, L. Moretta Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference Clin Immunol 133 2009 171 178
52. T. Klingebiel, J. Cornish, M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size. An analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant Group Blood 115 2010 3437 3446
53. W.A. Bethge, M. Haegele, C. Faul Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update Blood Cells Mol Dis 40 2008 13 19
54. P. Bader, J. Soerensen, A. Jarisch Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19 depleted stem cells Best Pract Res Clin Haematol 24 2011 331 337
55. S. Chaleff, M. Otto, R.C. Barfield A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation Cytotherapy 9 2007 746 754
56. K. Perruccio, A. Tosti, E. Burchielli Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation Blood 106 2005 4397 4406
57. T. Feuchtinger, K. Opherk, W.A. Bethge Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation Blood 116 2010 4360 4367
58. A.M. Leen, A. Christin, G.D. Myers Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation Blood 114 2009 4283 4292
59. P. Comoli, M.W. Schilham, S. Basso T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors J Immunother 31 2008 529 536
60. P. Comoli, S. Basso, M. Zecca Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation Am J Transplant 7 2007 1648 1655
61. S. Marktel, Z. Magnani, F. Ciceri Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation Blood 101 2003 1290 1298
62. F. Ciceri, C. Bonini, C. Gallo-Stampino, C. Bordignon Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation Cytotherapy 7 2005 144 149
63. A. Di Stasi, S.K. Tey, G. Dotti Inducible apoptosis as a safety switch for adoptive cell therapy N Engl J Med 365 2011 1673 1683
64. K. Perruccio, F. Topini, A. Tosti Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation Blood Cells Mol Dis 40 2008 76 83
65. S. Mielke, R. Nunes, K. Rezvani A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique Blood 111 2008 4392 4402
66. J.P. Bastien, G. Krosl, C. Therien Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease Blood 116 2010 4859 4869
67. D.C. Roy, M. Guerin, R.S. Boumedine Reduction in incidence of severe infections by transplantation of high doses of haploidentical T cells selectively depleted of alloreactive units ASH Annual Meeting 118 2011 3020 [abstract]
68. P. Hoffmann, J. Ermann, M. Edinger, C.G. Fathman, S. Strober Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389 399
69. M. Edinger, P. Hoffmann, J. Ermann CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 2003 1144 1150
70. M. Di Ianni, B. Del Papa, D. Cecchini Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications Clin Exp Immunol 156 2009 246 253
71. V.H. Nguyen, S. Shashidhar, D.S. Chang The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation Blood 111 2008 945 953
72. M. Di Ianni, F. Falzetti, A. Carotti Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928
73. C.G. Brunstein, J.S. Miller, Q. Cao Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood 117 2011 1061 1070
74. A. Trenado, F. Charlotte, S. Fisson Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia J Clin Invest 112 2003 1688 1696
75. S.R. Spellman, M. Eapen, B.R. Logan A perspective on the selection of unrelated donors and cord blood units for transplantation Blood 120 2012 259 265
76. K. Kärre A perfect mismatch Science 295 2002 2029 2031
77. L. Ruggeri, F. Aversa, M.F. Martelli, A. Velardi Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self Immunol Rev 214 2006 202 218
78. A. Velardi, L. Ruggeri, A. Mancusi, F. Aversa, F.T. Christiansen Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia Curr Opin Immunol 21 2009 525 530
79. P. Haas, P. Loiseau, R. Tamouza NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation Blood 117 2011 1021 1029
80. B. Foley, S. Cooley, M.R. Verneris NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions Blood 118 2011 2784 2792
81. K.C. Hsu, C.A. Keever-Taylor, A. Wilton Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes Blood 105 2005 4878 4884
82. K.C. Hsu, B. Dupont Natural killer cell receptors: regulating innate immune responses to hematologic malignancies Semin Hematol 42 2005 91 103
83. A.T. Björklund, M. Schaffer, C. Fauriat NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation Blood 115 2010 2686 2694
84. S.M. Davies, L. Ruggieri, T. DeFor Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants Killer immunoglobulin-like receptor Blood 100 2002 3825 3827
85. E.J. Lowe, V. Turner, R. Handgretinger T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation Br J Haematol 123 2003 323 326
86. M. Bornhauser, R. Schwerdtfeger, H. Martin, K.H. Frank, C. Theuser, G. Ehninger Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors Blood 103 2004 2860 2861
87. S.S. Farag, A. Bacigalupo, M. Eapen The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry Biol Blood Marrow Transplant 12 2006 876 884
88. N. Kröger, T. Binder, T. Zabelina Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation Transplantation 82 2006 1024 1030
89. T. Yabe, K. Matsuo, K. Hirayasu Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation Biol Blood Marrow Transplant 14 2008 75 87
90. S. Giebel, F. Locatelli, T. Lamparelli Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 2003 814 819
91. D.W. Beelen, H.D. Ottinger, S. Ferencik Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias Blood 105 2005 2594 2600
92. A.H. Elmaagacli, H. Ottinger, M. Koldehoff Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor Transplantation 79 2005 1741 1747
93. N. Kröger, B. Shaw, S. Iacobelli Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma Br J Haematol 129 2005 631 643
94. M.A. Dawson, A. Spencer Successful use of haploidentical stem-cell transplantation with KIR mismatch as initial therapy for poor-risk myelodysplastic syndrome J Clin Oncol 23 2005 4473 4474
95. R. Willemze, C.A. Rodrigues, M. Labopin KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia Leukemia 23 2009 492 500
96. C.G. Brunstein, J.E. Wagner, D.J. Weisdorf Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity Blood 113 2009 5628 5634
97. F. Ciceri, C. Bonini, M.T.L. Stanghellini Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study Lancet Oncol 10 2009 489 500
98. L. Vago, B. Forno, M.P. Sormani Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation Blood 112 2008 3488 3499
99. J.S. Miller, Y. Soignier, A. Panoskaltsis-Mortari Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 2005 3051 3057
100. J.E. Rubnitz, H. Inaba, R.C. Ribeiro NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia J Clin Oncol 28 2010 955 959
101. A. Curti, L. Ruggeri, A. D'Addio Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients Blood 118 2011 3273 3279
102. F. Romagné, P. André, P. Spee Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells Blood 114 2009 2667 2677
103. A. Velardi Natural revenge over cytomegalovirus Blood 119 2012 2438 2439
104. B. Foley, S. Cooley, M.R. Verneris Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function Blood 119 2012 2665 2674
105. J.C. Sun, L.L. Lanier NK cell development, homeostasis and function: parallels with CD8+ T cells Nat Rev Immunol 11 2011 645 657